Evidence map›Paper›PMID 31690133›Full record

ArticleJournal of enzyme inhibition and medicinal chemistry2020

Structure activity relationship studies on Amb639752: toward the identification of a common pharmacophoric structure for DGKα inhibitors.

Suresh Velnati, Alberto Massarotti, Annamaria Antona, Maria Talmon, Luigia Grazia Fresu, Alessandra Silvia Galetto, Daniela Capello, Alessandra Bertoni, Valentina Mercalli, Andrea Graziani and 2 more

Abstract read
In one paragraph

Article in Journal of enzyme inhibition and medicinal chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Metabolic Checkpoints in CD8International journal of biological sciences · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Diacylglycerol kinase is a keystone regulator of signaling relevant to the pathophysiology of asthma.American journal of physiology. Lung cellular and molecular physiology · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Immune Checkpoint Receptors Signaling in T Cells.International journal of molecular sciences · 2022
    Review
  11. Article
  12. Review
  13. Diacylglycerol Kinase alpha in X Linked Lymphoproliferative Disease Type 1.International journal of molecular sciences · 2021
    Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Suresh VelnatiDepartment of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
Alberto MassarottiDepartment of Pharmaceutical Sciences, University of Piemonte Orientale, Novara, Italy.
Annamaria AntonaDepartment of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
Maria TalmonDepartment of Health Sciences, School of Medicine, University of Piemonte Orientale, Novara, Italy.
Luigia Grazia FresuDepartment of Health Sciences, School of Medicine, University of Piemonte Orientale, Novara, Italy.
Alessandra Silvia GalettoDepartment of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
Daniela CapelloDepartment of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
Alessandra BertoniDepartment of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
Valentina MercalliDepartment of Pharmaceutical Sciences, University of Piemonte Orientale, Novara, Italy.
Andrea GrazianiUniversità Vita-Salute San Raffaele, Milan, Italy.
Gian Cesare TronDepartment of Pharmaceutical Sciences, University of Piemonte Orientale, Novara, Italy.
Gianluca BaldanziDepartment of Translational Medicine, University of Piemonte Orientale, Novara, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A series of analogues of Amb639752, a novel diacylglycerol kinase (DGK) inhibitor recently discovered by us via virtual screening, have been tested. The compounds were evaluated as DGK inhibitors on α, θ, and ζ isoforms, and as antagonists on serotonin receptors. From these assays emerged two novel compounds, namely

Indexed as

Cell MovementCell SurvivalDose-Response Relationship, DrugHEK293 CellsHumansIndolesLipoprotein LipaseLymphocytesMCF-7 CellsModels, MolecularMolecular StructureMonocytesPiperazinesProtein Kinase InhibitorsStructure-Activity RelationshipT-LymphocytesAMB639752DAGLA protein, humanIndolesLipoprotein LipasePiperazinesProtein Kinase InhibitorsDiacylglycerol kinaseenzyme assayskinase inhibitorsmolecular modellingstructure–activity relationship

Identifiers

PMID31690133
PMCPMC6844378

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.